Average Co-Inventor Count = 5.91
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (11 from 1,970 patents)
2. Ribon Therapeutics, Inc. (10 from 11 patents)
3. Boehringer Ingelheim International Gmbh (3 from 1,535 patents)
4. Teijin Pharma Limited (1 from 124 patents)
25 patents:
1. 12398146 - Heterobicyclic amides as inhibitors of CD38
2. 12371421 - Solid forms of a PARP7 inhibitor
3. 11987584 - Heterobicyclic amides as inhibitors of CD38
4. 11958837 - Quinazolinones as PARP14 inhibitors
5. 11952377 - Quinolines and azaquinolines as inhibitors of CD38
6. 11566020 - Pyridazinones as PARP7 inhibitors
7. 11535621 - Heterobicyclic amides as inhibitors of CD38
8. 11332459 - Benzimidazole derivatives and their uses
9. 11293927 - Screening methods for PARP modulators
10. 11014913 - Pyridazinones as PARP7 inhibitors
11. 11008308 - Quinazolinones as PARP14 inhibitors
12. 10870641 - Pyridazinones as PARP7 inhibitors
13. 10562891 - Quinazolinones as PARP14 inhibitors
14. 10550105 - Pyridazinones as PARP7 inhibitors
15. 9663508 - Biaryl acyl-sulfonamide compounds as sodium channel inhibitors